Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $104.86M.
ENTERPRISE VALUE (EV)
$104.86M
Lucid Diagnostics Inc.
Market Cap
$115.57M
Enterprise Value (EV)
$104.86M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Lucid Diagnostics Inc. (LUCD) | $115.57M | $104.86M |
| Genelux Corporation (GNLX)vs › | $116.14M | $109.37M |
| Caribou Biosciences, Inc. (CRBU)vs › | $116.27M | $116.73M |
| BGM Group Ltd. (BGM)vs › | $116.34M | $106.00M |
| LENZ Therapeutics, Inc. (LENZ)vs › | $116.75M | $92.67M |
| Coya Therapeutics, Inc. (COYA)vs › | $117.64M | N/A |
| Insight Molecular Diagnostics Inc. (IMDX)vs › | $113.34M | $98.21M |
| MaxCyte, Inc. (MXCT)vs › | $113.01M | $115.22M |
| Foghorn Therapeutics Inc. (FHTX)vs › | $112.73M | $87.75M |
| Aardvark Therapeutics, Inc. Common Stock (AARD)vs › | $111.61M | $38.44M |
Market Cap
$115.57M
Total Debt
$24.00M
Cash
$34.70M
Enterprise Value
$104.86M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
